yttrium radioisotopes has been researched along with Carcinoma, Non-Small Cell Lung in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feron, O; Gallez, B; Lucas, S; Masereel, B; Michiels, C; Vander Borght, T | 1 |
| Duan, J; Khazaeli, MB; LoBuglio, AF; Macey, DJ; Meredith, RF; Robert, F; Shen, S | 1 |
| Busby, EM; LoBuglio, AF; Robert, F | 1 |
| Albone, E; Berger, M; Grimm, L; Kirksey, Y; Masters, G; Sheedy, J; Singleton, J; Soltis, D; Wang, B; Yang, Q | 1 |
| Busby, E; Carey, D; Forero, A; Grizzle, WE; Khazaeli, MB; LoBuglio, AF; Meredith, RF; Robert, F; Shen, S | 1 |
3 trial(s) available for yttrium radioisotopes and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Improved prediction of myelotoxicity using a patient-specific imaging dose estimate for non-marrow-targeting (90)Y-antibody therapy.
Topics: Adult; Aged; Animals; Antigens, Neoplasm; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Glycoproteins; Humans; Indium Radioisotopes; Lumbar Vertebrae; Lung Neoplasms; Mice; Middle Aged; Radiation Dosage; Radioimmunotherapy; Radiometry; Thrombocytopenia; Yttrium Radioisotopes | 2002 |
Chemotherapy tolerance after radioimmunotherapy with 90Y-CC49 monoclonal antibody in patients with advanced non-small cell lung cancer: clinical effects and hematologic toxicity.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Tolerance; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Radioimmunotherapy; Retrospective Studies; Salvage Therapy; Treatment Outcome; Yttrium Radioisotopes | 2003 |
Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: effect of chelating agents and paclitaxel co-administration.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chelating Agents; Clinical Trials as Topic; Disease Progression; Edetic Acid; Female; Glycoproteins; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Paclitaxel; Pentetic Acid; Radioimmunotherapy; Radiometry; Thrombocytopenia; Treatment Outcome; Up-Regulation; Yttrium Radioisotopes | 2005 |
2 other study(ies) available for yttrium radioisotopes and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Monte Carlo Calculation of Radioimmunotherapy with (90)Y-, (177)Lu-, (131)I-, (124)I-, and (188)Re-Nanoobjects: Choice of the Best Radionuclide for Solid Tumour Treatment by Using TCP and NTCP Concepts.
Topics: Algorithms; Antibodies, Monoclonal; Carcinoma, Non-Small-Cell Lung; Computer Simulation; Humans; Iodine Radioisotopes; Lung; Lung Neoplasms; Lutetium; Models, Statistical; Monte Carlo Method; Nanomedicine; Neoplasms; Radiation Pneumonitis; Radioimmunotherapy; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Rhenium; Yttrium Radioisotopes | 2015 |
Radiotherapy of human xenograft NSCLC tumors in nude mice with a 90Y-labeled anti-tissue factor antibody.
Topics: Animals; Antibodies; Antigens; Carcinoma, Non-Small-Cell Lung; Endocytosis; Humans; Mice; Mice, Nude; Radiation Dosage; Thromboplastin; Tissue Distribution; Treatment Outcome; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2005 |